Company Filing History:
1 out of 50 
1 out of 2,359 
Years Active: 2015
Title: David Lankin: Innovator in Anti-Tuberculosis Peptide Development
Introduction
David Lankin, based in Schaumburg, IL, is an accomplished inventor dedicated to advancing medical treatments, particularly in the fight against tuberculosis (TB). With one patent to his name, he has made significant contributions to the field of pharmaceutical innovations, focusing on the development of anti-TB cyclic peptides.
Latest Patents
Lankin's notable patent relates to novel anti-TB cyclic peptides derived from the strain MJM5123. This invention includes a process for producing these peptides as well as a pharmaceutical composition designed for the prevention and treatment of mycobacterial infections. Remarkably, this composition is effective against both replicating and non-replicating strains of the bacteria, including multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains. As such, it holds great promise as a therapeutic agent for tuberculosis.
Career Highlights
Throughout his career, David Lankin has been affiliated with prominent institutions such as Myongji University Industry and Academia Cooperation Foundation and the University of Illinois. His work at these organizations has provided a foundation for his innovative research, leading him to develop groundbreaking therapies aimed at combating infectious diseases.
Collaborations
During his professional journey, Lankin has collaborated with notable peers, including Jong Woo Kim and Sang Wook Lee. These partnerships have been integral to his research and the successful development of his patented inventions, showcasing the power of teamwork in scientific advancements.
Conclusion
David Lankin's contributions to the pharmaceutical field, particularly in developing treatments for tuberculosis, represent a significant stride in medical innovations. His dedication as an inventor continues to inspire advancements in the fight against infectious diseases, demonstrating the vital role of research and collaboration in developing effective therapies.